{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T23:59:01Z","timestamp":1776988741878,"version":"3.51.4"},"reference-count":31,"publisher":"Spandidos Publications","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,3]]},"DOI":"10.3892\/or.2015.3730","type":"journal-article","created":{"date-parts":[[2015,1,15]],"date-time":"2015-01-15T14:27:05Z","timestamp":1421332025000},"page":"1551-1559","source":"Crossref","is-referenced-by-count":10,"title":["Silencing NOB1 enhances doxorubicin antitumor activity of the papillary thyroid carcinoma in vitro and in vivo"],"prefix":"10.3892","volume":"33","author":[{"given":"JIA","family":"LIU","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"BING-FEI","family":"DONG","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"PEI-SONG","family":"WANG","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"PEI-YOU","family":"REN","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"SHUAI","family":"XUE","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"XIAO-NAN","family":"ZHANG","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"ZHE","family":"HAN","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"GUANG","family":"CHEN","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2015,1,15]]},"reference":[{"key":"key20180107212734_b1-or-33-03-1551","doi-asserted-by":"crossref","first-page":"193","DOI":"10.7150\/jca.2.193","article-title":"Thyroid cancer: burden of illness and management of disease","volume":"2","author":"Brown","year":"2011","journal-title":"J Cancer"},{"key":"key20180107212734_b2-or-33-03-1551","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1089\/thy.2013.0011","article-title":"Outcomes of patients with differentiated thyroid cancer risk-stratified according to the American thyroid association and Latin American thyroid society risk of recurrence classification systems","volume":"23","author":"Pitoia","year":"2013","journal-title":"Thyroid"},{"key":"key20180107212734_b3-or-33-03-1551","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1177\/014556130608500201","article-title":"World Health Organization classification of tumours: pathology and genetics of head and neck tumours","volume":"85","author":"Thompson","year":"2006","journal-title":"Ear Nose Throat J"},{"key":"key20180107212734_b4-or-33-03-1551","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1586\/14737159.8.1.83","article-title":"Molecular genetics of thyroid cancer: implications for diagnosis, treatment and prognosis","volume":"8","author":"Nikiforova","year":"2008","journal-title":"Expert Rev Mol Diagn"},{"key":"key20180107212734_b5-or-33-03-1551","doi-asserted-by":"crossref","first-page":"3267","DOI":"10.2174\/092986709788803312","article-title":"Doxorubicin: the good, the bad and the ugly effect","volume":"16","author":"Carvalho","year":"2009","journal-title":"Curr Med Chem"},{"key":"key20180107212734_b6-or-33-03-1551","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/nrc706","article-title":"Multidrug resistance in cancer: role of ATP-dependent transporters","volume":"2","author":"Gottesman","year":"2002","journal-title":"Nat Rev Cancer"},{"key":"key20180107212734_b7-or-33-03-1551","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1056\/NEJM199511163332015","article-title":"Doxorubicin-induced cardiotoxicity","volume":"333","author":"Silber","year":"1995","journal-title":"N Engl J Med"},{"key":"key20180107212734_b8-or-33-03-1551","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1634\/theoncologist.6-2-162","article-title":"Hepatotoxicity of chemotherapy","volume":"6","author":"King","year":"2001","journal-title":"Oncologist"},{"key":"key20180107212734_b9-or-33-03-1551","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s11033-005-3141-7","article-title":"Cloning, expression and characterization of the human NOB1 gene","volume":"32","author":"Zhang","year":"2005","journal-title":"Mol Biol Rep"},{"key":"key20180107212734_b10-or-33-03-1551","doi-asserted-by":"crossref","first-page":"16471","DOI":"10.1074\/jbc.M313833200","article-title":"Distant structural homology leads to the functional characterization of an archaeal PIN domain as an exonuclease","volume":"279","author":"Arcus","year":"2004","journal-title":"J Biol Chem"},{"key":"key20180107212734_b11-or-33-03-1551","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/s12032-010-9808-5","article-title":"RNAi-mediated downregulation of NOB1 suppresses the growth and colony-formation ability of human ovarian cancer cells","volume":"29","author":"Lin","year":"2012","journal-title":"Med Oncol"},{"key":"key20180107212734_b12-or-33-03-1551","first-page":"2300","article-title":"Expression and clinical significance of the nin one binding protein and p38 MAPK in prostate carcinoma","volume":"6","author":"Che","year":"2013","journal-title":"Int J Clin Exp Pathol"},{"key":"key20180107212734_b13-or-33-03-1551","first-page":"2137","article-title":"Clinical significance of NOB1 expression in breast infiltrating ductal carcinoma","volume":"6","author":"Li","year":"2013","journal-title":"Int J Clin Exp Pathol"},{"key":"key20180107212734_b14-or-33-03-1551","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.3892\/or.2014.2991","article-title":"Downregulation of NOB1 suppresses the proliferation and tumor growth of non-small cell lung cancer in vitro and in vivo","volume":"31","author":"Li","year":"2014","journal-title":"Oncol Rep"},{"key":"key20180107212734_b15-or-33-03-1551","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.7314\/APJCP.2012.13.5.1823","article-title":"siRNA mediated silencing of NIN1\/RPN12 binding protein 1 homolog inhibits proliferation and growth of breast cancer cells","volume":"13","author":"Huang","year":"2012","journal-title":"Asian Pac J Cancer Prev"},{"key":"key20180107212734_b16-or-33-03-1551","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1007\/s11033-011-0764-8","article-title":"Downregulation of NIN\/RPN12 binding protein inhibit the growth of human hepatocellular carcinoma cells","volume":"39","author":"Lu","year":"2012","journal-title":"Mol Biol Rep"},{"key":"key20180107212734_b17-or-33-03-1551","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1177\/0300060513479862","article-title":"Expression of the NOB1 gene and its clinical significance in papillary thyroid carcinoma","volume":"41","author":"Lin","year":"2013","journal-title":"J Int Med Res"},{"key":"key20180107212734_b18-or-33-03-1551","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.3892\/or.2014.3483","article-title":"Adenovirus-mediated siRNA targeting NOB1 inhibits tumor growth and enhances radiosensitivity of human papillary thyroid carcinoma in vitro and in vivo","volume":"32","author":"Meng","year":"2014","journal-title":"Oncol Rep"},{"key":"key20180107212734_b19-or-33-03-1551","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1007\/s00280-002-0501-z","article-title":"Preoperative cisplatin for initial treatment of limb osteosarcoma: its local effect and impact on prognosis","volume":"50","author":"Abe","year":"2002","journal-title":"Cancer Chemother Pharmacol"},{"key":"key20180107212734_b20-or-33-03-1551","doi-asserted-by":"crossref","first-page":"e71071","DOI":"10.1371\/journal.pone.0071071","article-title":"Grape seed procyanidin reversal of P-glycoprotein associated multi-drug resistance via down-regulation of NF-\u03baB and MAPK\/ERK mediated YB-1 activity in A2780\/T cells","volume":"8","author":"Zhao","year":"2013","journal-title":"PLoS One"},{"key":"key20180107212734_b21-or-33-03-1551","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1097\/00001622-199701000-00013","article-title":"Role of oncogenes in resistance and killing by cancer therapeutic agents","volume":"9","author":"el-Deiry","year":"1997","journal-title":"Curr Opin Oncol"},{"key":"key20180107212734_b22-or-33-03-1551","doi-asserted-by":"crossref","first-page":"3142","DOI":"10.1101\/gad.1025602","article-title":"Nob1p is required for biogenesis of the 26S proteasome and degraded upon its maturation in Saccharomyces cerevisiae","volume":"16","author":"Tone","year":"2002","journal-title":"Genes Dev"},{"key":"key20180107212734_b23-or-33-03-1551","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0378-1119(99)00566-1","article-title":"Nob1p, a new essential protein, associates with the 26S proteasome of growing Saccharomyces cerevisiae cells","volume":"243","author":"Tone","year":"2000","journal-title":"Gene"},{"key":"key20180107212734_b24-or-33-03-1551","doi-asserted-by":"crossref","first-page":"4968","DOI":"10.1091\/mbc.E08-03-0259","article-title":"Cyclin G2 is degraded through the ubiquitin-proteasome pathway and mediates the antiproliferative effect of activin receptor-like kinase 7","volume":"19","author":"Xu","year":"2008","journal-title":"Mol Biol Cell"},{"key":"key20180107212734_b25-or-33-03-1551","doi-asserted-by":"crossref","first-page":"e17110","DOI":"10.1371\/journal.pone.0017110","article-title":"Thiazole antibiotic thiostrepton synergize with bortezomib to induce apoptosis in cancer cells","volume":"6","author":"Pandit","year":"2011","journal-title":"PLoS One"},{"key":"key20180107212734_b26-or-33-03-1551","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1158\/1535-7163.MCT-11-0745","article-title":"Bortezomib: understanding the mechanism of action","volume":"10","author":"Piperdi","year":"2011","journal-title":"Mol Cancer Ther"},{"key":"key20180107212734_b27-or-33-03-1551","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.drudis.2010.01.008","article-title":"Building on bortezomib: second-generation proteasome inhibitors as anti-cancer therapy","volume":"15","author":"Dick","year":"2010","journal-title":"Drug Discov Today"},{"key":"key20180107212734_b28-or-33-03-1551","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S1046-2023(02)00023-3","article-title":"Analysis of gene function in somatic mammalian cells using small interfering RNAs","volume":"26","author":"Elbashir","year":"2002","journal-title":"Methods"},{"key":"key20180107212734_b29-or-33-03-1551","doi-asserted-by":"crossref","first-page":"3279","DOI":"10.1038\/sj.onc.1210421","article-title":"MAP kinase signalling pathways in cancer","volume":"26","author":"Dhillon","year":"2007","journal-title":"Oncogene"},{"key":"key20180107212734_b30-or-33-03-1551","doi-asserted-by":"crossref","first-page":"e68469","DOI":"10.1371\/journal.pone.0068469","article-title":"MicroRNA-326 functions as a tumor suppressor in glioma by targeting the Nin one binding protein (NOB1)","volume":"8","author":"Zhou","year":"2013","journal-title":"PLoS One"},{"key":"key20180107212734_b31-or-33-03-1551","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1038\/bjc.2014.382","article-title":"Downregulated miR-646 in clear cell renal carcinoma correlated with tumour metastasis by targeting the nin one binding protein (NOB1)","volume":"111","author":"Li","year":"2014","journal-title":"Br J Cancer"}],"updated-by":[{"DOI":"10.3892\/or.2022.8297","type":"retraction","label":"Retraction","source":"retraction-watch","updated":{"date-parts":[[2022,6,14]],"date-time":"2022-06-14T00:00:00Z","timestamp":1655164800000},"record-id":"37818"}],"container-title":["Oncology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/or.2015.3730\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,19]],"date-time":"2019-08-19T19:09:13Z","timestamp":1566241753000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/or.2015.3730"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1,15]]},"references-count":31,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2015,1,15]]},"published-print":{"date-parts":[[2015,3]]}},"alternative-id":["10.3892\/or.2015.3730"],"URL":"https:\/\/doi.org\/10.3892\/or.2015.3730","relation":{},"ISSN":["1021-335X","1791-2431"],"issn-type":[{"value":"1021-335X","type":"print"},{"value":"1791-2431","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,1,15]]}}}